Vaccines Articles
Researchers have concluded a Phase II study of an investigational vaccine against group B Neisseria meningitidis, which shows promising results.
Researchers tested a third dose of the measles-mumps-rubella vaccine on students in an affected community in an effort to control the outbreak.
Despite only 29 human cases of the new strain of swine flu in the past two years, the Centers for Disease Control and Prevention (CDC) is preparing an H3N2 candidate vaccine, and clinical trials are being planned for this year.
Researchers at the University ofBritish Columbia (UBC) have found that the swine flu vaccine triggers antibodies that protect against many flu viruses, including the lethal bird flu strain.
New research suggests it might someday be possible to create a vaccine that could protect a growing fetus from premature birth and related complications.
Recent studies of the flu virus are bringing hope that seasonal flu vaccines will be replaced with long-lasting universal vaccines.
A synthetic vaccine based on nanotechnology may halt autoimmune diseases such as Crohn’s and rheumatoid arthritis.
Preliminary results from a Phase III clinical trial in Africa showed that a malaria vaccine, known as RTS,S, cut the number of malaria cases by 50 percent in a 12-month period following vaccination.
A vaccine that jump-starts the immune system is showing promise in keeping patients diagnosed with glioblastoma, or malignant glioma, alive longer.
Researchers with the Centers for Disease Control and Prevention have found that influenza vaccination coverage is well below the Healthy People 2020 objectives.
U.S. investigators assessed vaccine effectiveness during the 2010-2011 season in an attempt to characterize the relationship between antigenic characteristics of circulating viruses and effectiveness of seasonal influenza vaccines.
U.S. Army Col. George Peoples, chief of surgical oncology at the San Antonio Military Medical Center, says he has come up with a vaccine he thinks will prevent cancer.